SHR # 2233 :: SFH: New Anti-obesity Drug Reduces Hepatic and Intramuscular Fat :: Dr. Jeff Golini, PhD - You heard it here first. Scientist in Australia went searching for an enzyme responsible for the onset of Type 2 #Diabetes and found a way to reverse the infiltration of fat into liver and muscle tissue. They are now embarking on launching a new #antiobesity drug instead of a Type 2 Diabetes drug. This drug could also help the millions of people who suffer from #NAFLD. PLUS Why Carl tapes his mouth shut at night while he's sleeping. It all started when he was in Los Angeles at the Quest Think Tank. PLUS Metagenics is a 30 year old nutraceutical company that spends over $7 million a year on R and D. ::